11956

    543654

    MEDANTA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GLOBAL HEALTH LIMITED Share Price Today

    GLOBAL HEALTH LIMITED is currently trading at ₹1348.3, up by ₹43.3 from the previous close. The stock touched an intraday high of ₹1356.00 and a low of ₹1316.30 during the latest trading session. Over the past one year, GLOBAL HEALTH LIMITED has delivered a return of 7.13%, while the stock has gained 7.81% in the last one month.

    GLOBAL HEALTH LIMITED performance

    Today’s low Today’s high
    ₹ 1316.30 ₹ 1356.00
    ₹ 1353.10
    52 week low 52 week high
    ₹ 956.00 ₹ 1456.50
    ₹ 1353.10
    Open Price ₹ 1323.00
    Prev. Close ₹ 1305.00
    Volume (Shares) 56286.00
    Total traded value ₹ 761.60
    Upper Circuit ₹ 1566.00
    Lower Circuit ₹ 1044.00
    info

    Investment Returns

    Over 1 Month 7.81% Over 3 Months 23.25% Over 6 Months 8.65% Over 1 Year 7.13%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GLOBAL HEALTH LIMITED fundamentals


    • Market cap (Cr) 36,381.00
    • P/E Ratio (TTM) 70.75
    • Beta 0.69
    • Book Value / share 149.23
    • Return on equity 14.13%
    • EPS (TTM) 18.45
    • Dividend yield 0.04%
    • Net profit/quarter (Cr) 124.13
    info icon alternate text
    • Market cap (Cr) 36,243.90
    • P/E Ratio (TTM) 70.75
    • Beta 0.63
    • Book Value / share 149.23
    • Return on equity 14.13%
    • EPS (TTM) 18.45
    • Dividend yield 0.04%
    • Net profit/quarter (Cr) 124.13
    info icon alternate text

    GLOBAL HEALTH LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 960.63
    Operating Expense 832.96
    Net Profit 124.13
    Net Profit Margin (%) 12.92
    Earnings Per Share (EPS) 4.62
    EBITDA 229.15
    Effective Tax Rate (%) 24.06
    Particulars DEC 2025 (Values in Cr)
    Revenue 940.17
    Operating Expense 826.74
    Net Profit 79.91
    Net Profit Margin (%) 8.49
    Earnings Per Share (EPS) 2.97
    EBITDA 163.82
    Effective Tax Rate (%) 22.33
    Particulars SEP 2025 (Values in Cr)
    Revenue 926.43
    Operating Expense 780.16
    Net Profit 140.20
    Net Profit Margin (%) 15.13
    Earnings Per Share (EPS) 5.22
    EBITDA 231.36
    Effective Tax Rate (%) 24.23
    Particulars JUN 2025 (Values in Cr)
    Revenue 882.16
    Operating Expense 726.64
    Net Profit 151.96
    Net Profit Margin (%) 17.22
    Earnings Per Share (EPS) 5.66
    EBITDA 237.32
    Effective Tax Rate (%) 23.34
    Particulars MAR 2025 (Values in Cr)
    Revenue 802.87
    Operating Expense 652.75
    Net Profit 93.41
    Net Profit Margin (%) 11.63
    Earnings Per Share (EPS) 3.48
    EBITDA 170.97
    Effective Tax Rate (%) 25.80
    Particulars MAR 2026 (Values in Cr)
    Revenue 3709.38
    Operating Expense 3166.14
    Net Profit 496.20
    Net Profit Margin (%) 13.37
    Earnings Per Share (EPS) 18.46
    EBITDA 861.65
    Effective Tax Rate (%) 23.62
    Particulars MAR 2025 (Values in Cr)
    Revenue 3204.15
    Operating Expense 2622.00
    Net Profit 461.53
    Net Profit Margin (%) 14.40
    Earnings Per Share (EPS) 17.18
    EBITDA 806.05
    Effective Tax Rate (%) 25.92
    Particulars MAR 2024 (Values in Cr)
    Revenue 2974.72
    Operating Expense 2406.46
    Net Profit 486.35
    Net Profit Margin (%) 16.34
    Earnings Per Share (EPS) 13.44
    EBITDA 835.20
    Effective Tax Rate (%) 26.18
    Particulars MAR 2023 (Values in Cr)
    Revenue 1973.54
    Operating Expense 1669.42
    Net Profit 263.25
    Net Profit Margin (%) 13.33
    Earnings Per Share (EPS) 10.16
    EBITDA 463.96
    Effective Tax Rate (%) 25.15
    Particulars MAR 2022 (Values in Cr)
    Revenue 1764.96
    Operating Expense 1504.15
    Net Profit 218.79
    Net Profit Margin (%) 12.39
    Earnings Per Share (EPS) 8.68
    EBITDA 410.58
    Effective Tax Rate (%) 26.04
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 126.08
    ROE % 15.30
    ROCE % 17.87
    Total Debt to Total Equity 0.24
    EBITDA Margin 24.79
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 108.22
    ROE % 17.93
    ROCE % 18.96
    Total Debt to Total Equity 0.36
    EBITDA Margin 26.98
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 90.54
    ROE % 16.13
    ROCE % 16.49
    Total Debt to Total Equity 0.55
    EBITDA Margin 25.30
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 63.82
    ROE % 13.09
    ROCE % 14.05
    Total Debt to Total Equity 0.68
    EBITDA Margin 22.91
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 272.22
    ROE % 2.11
    ROCE % 4.43
    Total Debt to Total Equity 0.68
    EBITDA Margin 15.78
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 130.22
    ROE % 14.13
    ROCE % 17.58
    Total Debt to Total Equity 0.12
    EBITDA Margin 25.38
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 113.11
    ROE % 17.60
    ROCE % 22.05
    Total Debt to Total Equity 0.13
    EBITDA Margin 28.36
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 92.80
    ROE % 12.45
    ROCE % 15.41
    Total Debt to Total Equity 0.14
    EBITDA Margin 23.80
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 68.70
    ROE % 13.57
    ROCE % 16.88
    Total Debt to Total Equity 0.17
    EBITDA Margin 23.56
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 292.65
    ROE % 3.99
    ROCE % 6.57
    Total Debt to Total Equity 0.08
    EBITDA Margin 16.40
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1122.33
    Total Assets 4766.23
    Total Liabilities 4766.23
    Total Equity 3387.50
    Share Outstanding 26
    Price to Book Ratio 9.20
    Return on Assets (%) 10.10
    Return on Capital (%) 12.96
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1175.28
    Total Assets 4304.07
    Total Liabilities 4304.07
    Total Equity 2905.59
    Share Outstanding 26
    Price to Book Ratio 11.70
    Return on Assets (%) 11.11
    Return on Capital (%) 14.38
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1278.10
    Total Assets 4115.96
    Total Liabilities 4115.96
    Total Equity 2428.20
    Share Outstanding 26
    Price to Book Ratio 5.67
    Return on Assets (%) 7.92
    Return on Capital (%) 9.97
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 511.80
    Total Assets 3145.51
    Total Liabilities 3145.51
    Total Equity 1616.01
    Share Outstanding 25
    Price to Book Ratio 0.00
    Return on Assets (%) 6.23
    Return on Capital (%) 8
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 289.30
    Total Assets 2694.10
    Total Liabilities 2694.10
    Total Equity 1382.34
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) 1.06
    Return on Capital (%) 1.42
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1052.78
    Total Assets 4440.58
    Total Liabilities 4440.58
    Total Equity 3497.60
    Share Outstanding 26
    Price to Book Ratio 9.20
    Return on Assets (%) 10.39
    Return on Capital (%) 12.69
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1137.30
    Total Assets 4008.55
    Total Liabilities 4008.55
    Total Equity 3037.03
    Share Outstanding 26
    Price to Book Ratio 11.70
    Return on Assets (%) 12.13
    Return on Capital (%) 14.93
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1144.82
    Total Assets 3178.70
    Total Liabilities 3178.70
    Total Equity 2488.86
    Share Outstanding 26
    Price to Book Ratio 5.67
    Return on Assets (%) 8.28
    Return on Capital (%) 10.16
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 441.33
    Total Assets 2361.33
    Total Liabilities 2361.33
    Total Equity 1739.75
    Share Outstanding 25
    Price to Book Ratio 0.00
    Return on Assets (%) 9.26
    Return on Capital (%) 11.75
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 254.77
    Total Assets 2002.11
    Total Liabilities 2002.11
    Total Equity 1483.63
    Share Outstanding 4
    Price to Book Ratio 0.00
    Return on Assets (%) 2.86
    Return on Capital (%) 3.8
    Particulars MAR 2025 (Values in Cr)
    Net Income 647.25
    Cash from Operations 787.99
    Cash from Investing -720.94
    Cash from Financing -97.22
    Net change in Cash -194.40
    Free Cash Flow 1304.54
    Particulars MAR 2024 (Values in Cr)
    Net Income 627.09
    Cash from Operations 789.54
    Cash from Investing -440.79
    Cash from Financing -513.92
    Net change in Cash -342.63
    Free Cash Flow 1068.13
    Particulars MAR 2023 (Values in Cr)
    Net Income 449.29
    Cash from Operations 750.66
    Cash from Investing -342.34
    Cash from Financing 345.63
    Net change in Cash 647.81
    Free Cash Flow 986.65
    Particulars MAR 2022 (Values in Cr)
    Net Income 280.55
    Cash from Operations 409.28
    Cash from Investing -420.88
    Cash from Financing 159.58
    Net change in Cash 49.96
    Free Cash Flow 683.75
    Particulars MAR 2021 (Values in Cr)
    Net Income 32.46
    Cash from Operations 258.16
    Cash from Investing -239.15
    Cash from Financing -80.72
    Net change in Cash -78.10
    Free Cash Flow 403.90
    Particulars MAR 2025 (Values in Cr)
    Net Income 623.04
    Cash from Operations 688.40
    Cash from Investing -638.20
    Cash from Financing -94.49
    Net change in Cash -205.02
    Free Cash Flow 1116.09
    Particulars MAR 2024 (Values in Cr)
    Net Income 658.85
    Cash from Operations 733.10
    Cash from Investing -518.86
    Cash from Financing -379.49
    Net change in Cash -338.98
    Free Cash Flow 958.71
    Particulars MAR 2023 (Values in Cr)
    Net Income 351.70
    Cash from Operations 531.47
    Cash from Investing -257.28
    Cash from Financing 404.22
    Net change in Cash 577.46
    Free Cash Flow 647.49
    Particulars MAR 2022 (Values in Cr)
    Net Income 295.82
    Cash from Operations 326.18
    Cash from Investing -312.99
    Cash from Financing 97.59
    Net change in Cash 20.00
    Free Cash Flow 390.76
    Particulars MAR 2021 (Values in Cr)
    Net Income 84.42
    Cash from Operations 215.51
    Cash from Investing -250.46
    Cash from Financing -36.66
    Net change in Cash -86.24
    Free Cash Flow 241.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8749.80 64.31 13.28 125808.70 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 50.66 22.92 2.76 94.95 40.75 76.00
    SHREE PACETRONIX LTD. 134.55 16.06 2.83 50.45 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.09 0.00 2.79 23.41 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8749.80 83.80 12.62 125808.70 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.53 0.00 -9.37 28.78 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5961.10 26.68 4.94 6521.44 5010.00 6725.00

    GLOBAL HEALTH LIMITED shareholding pattern

    Holding
    42.07%
    33.0%
    10.14%
    14.76%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    GLOBAL HEALTH LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1353.10 3.68 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1333.80
    • 26 Days 1280.40
    • 10 Days 1320.70
    • 50 Days 1238.60
    • 12 Days 1314.90
    • 100 Days 1201.80
    • 20 Days 1293.80
    • 200 Days 1193.70
    1313.87 PIVOT
    First Support 1287.03 First Resistance 1331.83 Second Support 1269.07 Second Resistance 1358.67 Third Support 1242.23 Third Resistance 1376.63
    RSI 63.05 ADX 29.20 MACD 34.55 Williams % R -33.98 Commodity Channel Index (CCI) 72.67
    Date 2026-07-08 Week 82219.00 Same Day 110056.00 Month 159316.00
    1 Year 0.69 3 Year 0.67
    Over 1 Month
    7.81% down
    Over 1 Year
    7.13% down
    Over 3 Months
    23.25% down
    Over 3 Years
    23.44% down
    Over 6 Months
    8.65% down
    Over 5 Years
    0.00% down

    GLOBAL HEALTH LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Aug 2025 0.5 Final 22 Aug 2025 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Aug 2025 0.5 Final 22 Aug 2025 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Global Health Ltd?

    Answer Field

    Global Health Ltd share price is for NSE ₹ 1,348.30 & for BSE ₹ 1,348.00 as on Jul 09 2026 03:30 PM.

    What is the Market Cap of Global Health Ltd Share?

    Answer Field

    The market cap of Global Health Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 09 2026 03:30 PM.

    What is the 52 Week High and Low of Global Health Ltd?

    Answer Field

    The 52 Week High and Low of Global Health Ltd for NSE is ₹ 1,456.50 and ₹ 956.00 and for BSE is ₹ 1,455.85 and ₹ 955.20.

    What is 1 year return for Global Health Ltd?

    Answer Field

    The 1 year returns on the stock has been 7.13%.

    What is the P/E Ratio of Global Health Ltd Share?

    Answer Field

    As on Jul 09 2026 03:30 PM the price-to-earnings (PE) ratio for Global Health Ltd share is 70.75.

    What is the PB ratio of Global Health Ltd Share?

    Answer Field

    As on Jul 09 2026 03:30 PM, the price-to-book (PB) ratio for Global Health Ltd share is 149.23.

    How to Buy Global Health Ltd Share?

    Answer Field

    You can trade in Global Health Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Global Health Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Global Health Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Global Health Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |